250 related articles for article (PubMed ID: 7884761)
1. A review of the mechanisms of oral tolerance and immunotherapy.
Sosroseno W
J R Soc Med; 1995 Jan; 88(1):14-7. PubMed ID: 7884761
[TBL] [Abstract][Full Text] [Related]
2. Cellular Components and Mechanisms of Oral Tolerance Induction.
Rezende RM; Weiner HL
Crit Rev Immunol; 2018; 38(3):207-231. PubMed ID: 30004858
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
Jiang S; Lechler RI
Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
[TBL] [Abstract][Full Text] [Related]
4. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
Moingeon P; Mascarell L
Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
[TBL] [Abstract][Full Text] [Related]
5. Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.
Nicolson KS; Wraith DC
Inflamm Allergy Drug Targets; 2006 Sep; 5(3):141-8. PubMed ID: 16918477
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
Wauben MH
Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
[TBL] [Abstract][Full Text] [Related]
7. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
[TBL] [Abstract][Full Text] [Related]
8. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
[TBL] [Abstract][Full Text] [Related]
9. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
[TBL] [Abstract][Full Text] [Related]
10. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens.
Friedman A; al-Sabbagh A; Santos LM; Fishman-Lobell J; Polanski M; Das MP; Khoury SJ; Weiner HL
Chem Immunol; 1994; 58():259-90. PubMed ID: 8011155
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic manipulation of immune tolerance in allergic disease.
Akdis M; Akdis CA
Nat Rev Drug Discov; 2009 Aug; 8(8):645-60. PubMed ID: 19644474
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for the therapeutic induction of tolerance.
Waldmann H; Qin S; Cobbold SP
Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
[No Abstract] [Full Text] [Related]
13. Potentiation of immunological tolerance induction in adult mice by co-administration of pooled normal IgG and oral tolerogens: a potential therapeutic approach for autoimmune diseases.
Mengel J; Fávaro P; Meyer A; Motta V; de Alencar R; Postól E; Cardillo F
Med Hypotheses; 2005; 64(5):978-85. PubMed ID: 15780495
[TBL] [Abstract][Full Text] [Related]
14. Oral tolerance: an updated review.
Rezende RM; Weiner HL
Immunol Lett; 2022 May; 245():29-37. PubMed ID: 35395272
[TBL] [Abstract][Full Text] [Related]
15. Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases.
Ma S; Liao YC; Jevnikar AM
Curr Pharm Biotechnol; 2015; 16(11):1002-11. PubMed ID: 26306744
[TBL] [Abstract][Full Text] [Related]
16. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
17. Oral tolerance in the treatment of rheumatoid arthritis.
Toussirot EA
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):45-52. PubMed ID: 14561205
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
[TBL] [Abstract][Full Text] [Related]
20. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression].
Matsui M
Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
